The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 360:886-892 February 26, 2009 Number 9
NextNext

Emergence of Ciprofloxacin-Resistant Neisseria meningitidis in North America
Henry M. Wu, M.D., Brian H. Harcourt, Ph.D., Cynthia P. Hatcher, B.S., Stanley C. Wei, M.D., Ryan T. Novak, Ph.D., Xin Wang, Ph.D., Billie A. Juni, M.S., Anita Glennen, B.S., David J. Boxrud, M.S., Jean Rainbow, R.N., M.P.H., Susanna Schmink, B.S., Raydel D. Mair, B.S., M. Jordan Theodore, B.S., Molly A. Sander, M.P.H., Tracy K. Miller, M.P.H., Kirby Kruger, B.S., Amanda C. Cohn, M.D., Thomas A. Clark, M.D., M.P.H., Nancy E. Messonnier, M.D., Leonard W. Mayer, Ph.D., and Ruth Lynfield, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
SUMMARY

We report on three cases of meningococcal disease caused by ciprofloxacin-resistant Neisseria meningitidis, one in North Dakota and two in Minnesota. The cases were caused by the same serogroup B strain. To assess local carriage of resistant N. meningitidis, we conducted a pharyngeal-carriage survey and isolated the resistant strain from one asymptomatic carrier. Sequencing of the gene encoding subunit A of DNA gyrase (gyrA) revealed a mutation associated with fluoroquinolone resistance and suggests that the resistance was acquired by means of horizontal gene transfer with the commensal N. lactamica. In susceptibility testing of invasive N. meningitidis isolates from the Active Bacterial Core surveillance system between January 2007 and January 2008, an additional ciprofloxacin-resistant isolate was found, in this case from California. Ciprofloxacin-resistant N. meningitidis has emerged in North America.


Source Information

From the Epidemic Intelligence Service Program, Office of Workforce and Career Development (H.M.W., S.C.W.), and the Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases (H.M.W., B.H.H., C.P.H., S.C.W., R.T.N., X.W., S.S., R.D.M., M.J.T., A.C.C., T.A.C., N.E.M., L.W.M.), Centers for Disease Control and Prevention, Atlanta; the Emerging Infections Program, Minnesota Department of Health, St. Paul (B.A.J., A.G., D.J.B., J.R., R.L.); and the North Dakota Department of Health, Bismarck (M.A.S., T.K.M., K.K.).

Address reprint requests to Dr. Wu at the Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS C-09, Atlanta, GA 30333, or at hwu{at}cdc.gov.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.